Axon Enterprise, Inc (NASDAQ:AXON) is Jag Capital Management LLC's 10th Largest Position

Jag Capital Management LLC lessened its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 40,353 shares of the biotechnology company's stock after selling 2,527 shares during the period. Axon Enterprise comprises 2.8% of Jag Capital Management LLC's holdings, making the stock its 10th biggest position. Jag Capital Management LLC owned 0.05% of Axon Enterprise worth $21,224,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Axon Enterprise in the first quarter worth about $1,110,000. CX Institutional acquired a new stake in Axon Enterprise in the first quarter valued at approximately $115,000. Blue Trust Inc. boosted its stake in Axon Enterprise by 33.1% in the first quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company's stock valued at $89,000 after acquiring an additional 42 shares in the last quarter. Xponance Inc. increased its position in shares of Axon Enterprise by 3.5% during the fourth quarter. Xponance Inc. now owns 16,469 shares of the biotechnology company's stock worth $9,788,000 after purchasing an additional 560 shares in the last quarter. Finally, Brighton Jones LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth $480,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

NASDAQ:AXON traded up $14.65 during trading hours on Friday, reaching $818.60. The company had a trading volume of 1,010,596 shares, compared to its average volume of 540,419. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. Axon Enterprise, Inc has a 1-year low of $279.02 and a 1-year high of $820.83. The business's 50 day moving average price is $714.97 and its 200-day moving average price is $630.47. The firm has a market cap of $63.73 billion, a PE ratio of 197.73, a price-to-earnings-growth ratio of 94.23 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.15 earnings per share. Research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analysts Forecast Growth

AXON has been the topic of several recent analyst reports. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Bank of America boosted their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Finally, Barclays raised their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $699.55.

Insider Transactions at Axon Enterprise

In other news, CFO Brittany Bagley sold 3,400 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total value of $2,380,000.00. Following the completion of the sale, the chief financial officer now directly owns 131,833 shares in the company, valued at $92,283,100. The trade was a 2.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, President Joshua Isner sold 905 shares of Axon Enterprise stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now directly owns 268,735 shares in the company, valued at $208,643,166.65. This represents a 0.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 44,642 shares of company stock valued at $30,500,428 in the last ninety days. 4.40% of the stock is currently owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.